Physician profile
Brooke Benjamin
NPI 1417352360
$1,828.77
in general payments reported to CMS, 2019-2025
20 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $768 · 2023: $244 · 2024: $66.50 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $402.29 | 2021-2023 | |
| Abbvie INC. | $252.52 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $194.58 | 2021-2023 | Belbuca, Xtampza |
| Nevro Corp. | $144.72 | 2022 | |
| Medtronic, INC. | $133.19 | 2022 | |
| Avanos Medical | $124.86 | 2021 | |
| Ucb, INC. | $124.38 | 2025 | Briviact |
| Pfizer INC. | $109.94 | 2025 | |
| Redhill Biopharma INC. | $59.05 | 2021-2022 | |
| Amgen INC. | $57.79 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.62 | 2022 | |
| Biodelivery Sciences International, INC. | $44.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $27.88 | 2021 | |
| Vertos Medical, INC. | $24.18 | 2022 | |
| Alfasigma USA, INC. | $16.60 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $15.85 | 2022 | |
| Hikma Pharmaceuticals USA | $14.74 | 2022 | |
| Chiesi USA, INC. | $13.70 | 2025 | Cleviprex |
| Itamar Medical INC | $12.14 | 2023 | Watchpatone |
| Electronic Waveform Lab, INC. | $10.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.